Name | Title | Contact Details |
---|
BTG is a global healthcare company focused on Interventional Medicine. Our innovative medical technology helps physicians treat their patients through minimally invasive procedures. Today we have a growing portfolio of products that advance the treatment of cancer, vascular conditions and severe emphysema. Our Pharmaceuticals business provides products that help patients overexposed to certain medications or toxins. Our mission is to provide imaginative new ways to treat disease; making a real difference for patients, and a valuable contribution to healthcare. As medicine moves from major surgery to minor procedure, no company endeavours to do more to help doctors in their quest to see more, reach further and treat smarter. We understand their needs and equip them with tools and techniques that would have seemed like science fiction only a generation ago. We invest in clinical evidence that helps demonstrate the value of our treatments to patients, doctors, and healthcare systems. With relentless curiosity we`ll work with clinicians to find elegant new ways to extend our power over disease and transform patient care. There are no limits to where our ideas will take us.
Mission of Mercy is a community-based organization providing free healthcare and free prescription medications to the uninsured, under-insured.
First Service Administrators is a Winter Haven, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Legacy is America`s largest at-home fertility clinic for people with sperm, empowering individuals to learn more about their sperm and proactively plan for their future with secure sperm freezing options. Partnering with leading health plans, fertility benefits providers, US military programs, and financing merchants, Legacy is making industry-leading sperm testing and freezing affordable and accessible.
OSCOR Inc. designs, develops, manufactures and markets a variety of highly specialized implantable cardiac pacing leads, venous access systems and diagnostic catheters. Oscor is also leveraging its proprietary lead technologies toward the development